From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA)
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Ines Tapken und 10 weiteren Autor:innen. Beteiligte Einrichtung: SMATHERIA gGmbH - Non-Profit Biomedical Research Institute, Feodor-Lynen-Str. 31, Hannover 30625, Germany. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Disease Models, Animal, Artificial Intelligence, Computational Biology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Deutsche Muskelstiftung, Philipp & Freunde-SMA Deutschland, Philipp & Freunde—SMA Deutschland.
Abstract (Originalsprache)
Spinal Muscular Atrophy is caused by partial loss of survival of motoneuron (SMN) protein expression. The numerous interaction partners and mechanisms influenced by SMN loss result in a complex disease. Current treatments restore SMN protein levels to a certain extent, but do not cure all symptoms. The prolonged survival of patients creates an increasing need for a better understanding of SMA. Although many SMN-protein interactions, dysregulated pathways, and organ phenotypes are known, the connections among them remain largely unexplored. Monogenic diseases are ideal examples for the exploration of cause-and-effect relationships to create a network describing the disease-context. Machine learning tools can utilize such knowledge to analyze similarities between disease-relevant molecules and molecules not described in the disease so far. We used an artificial intelligence-based algorithm to predict new genes of interest. The transcriptional regulation of 8 out of 13 molecules selected from the predicted set were successfully validated in an SMA mouse model. This bioinformatic approach, using the given experimental knowledge for relevance predictions, enhances efficient targeted research in SMA and potentially in other disease settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SMATHERIA gGmbH - Non-Profit Biomedical Research Institute, Feodor-Lynen-Str. 31, Hannover 30625, Germany.
- Center for Systems Neuroscience (ZSN), Bünteweg 2, Hannover 30559, Germany.
- Hannover Medical School, Department of Conservative Dentistry, Periodontology and Preventive Dentistry, Carl-Neuberg-Str. 1, Hannover 30625, Germany.
- QIAGEN Digital Insights, 1001 Marshall Street,Redwood City, CA 94063, United States.
Förderung
- Deutsche Muskelstiftung
- Philipp & Freunde-SMA Deutschland
- Philipp & Freunde—SMA Deutschland
Zitieren
APA
Tapken, I., Kuhn, D., Hoffmann, N., Detering, N. T., Schüning, T., Billaud, J. N., Tugendreich, S., Schlüter, N., Green, J., Krämer, A., & Claus, P. (2024). From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA). Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae076
Vancouver
Tapken I, Kuhn D, Hoffmann N, Detering NT, Schüning T, Billaud JN, et al. From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA). Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae076
BibTeX
@article{Tapken2024,
author = {Tapken, Ines and Kuhn, Daniela and Hoffmann, Nico and Detering, Nora T and Schüning, Tobias and Billaud, Jean-Noël and Tugendreich, Stuart and Schlüter, Nadine and Green, Jeff and Krämer, Andreas and Claus, Peter},
title = {From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA)},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae076}
}
EUVIMED